Clinical trial
The VANcomycin Cohort Study - Assessing Precise Dosing and Prompt Drug Monitoring to Improve Attainment of Target Concentrations (Part 2)
NCT05770622 is registered in ClinicalTrials.gov with Murdoch Childrens Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The VANcomycin Cohort Study - Assessing Precise Dosing and Prompt Drug Monitoring to Improve Attainment of Target Concentrations (Part 2)
- Lead sponsor
- Murdoch Childrens Research Institute
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- November 10, 2024
- Completion date
- April 30, 2027
- Enrollment
- 40 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.